The Supreme Court of Delaware recently affirmed a decision by the Court of Chancery that ordered a corporation to produce certain books and records to a shareholder, and which granted leave to the shareholder to take a...more
On October 1, 2019, the Delaware Court of Chancery issued its decision in In re Clovis Oncology, Inc. Derivative Litigation, C.A. No. 2017-0222-JRS (Del. Ch. Oct. 1, 2019), which addresses the duties of directors to oversee...more
10/30/2019
/ Board of Directors ,
Breach of Duty ,
Caremark claim ,
Clinical Trials ,
Corporate Governance ,
DE Supreme Court ,
Derivative Suit ,
Enforcement Actions ,
Internal Controls ,
Oversight Duties ,
Pharmaceutical Industry ,
Popular ,
Securities and Exchange Commission (SEC)